P6

Tamoxifen, a selective estrogen receptor modulator, remains a standard of endocrine therapy for estrogen receptor alpha (ERα) positive breast cancer (Goldhirsch et al., 2013). Despite well-known advantages of tamoxifen treatment, approximately one third of patients experience a relapse or disease pr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: N. Babyshkina, S. Vtorushin, S. Patalyak, T. Dronova, E. Slonimskaya, N.Cherdyntseva
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2015-11-01
Serija:EJC Supplements
Online dostop:http://www.sciencedirect.com/science/article/pii/S1359634915000051
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki